Invesco’s Pardes Biosciences, Inc. Common Stock PRDS Stock Holding History

Invesco’s Portfolio PRDS Stock Details PRDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-11,333	Closed	-$15K	–	3997
2023 Q1	$15K	Sell	11,333 -821	-7%	-$1.34K	﹤0.01%	3827
2022 Q4	$20.5K	Hold	12,154	–	–	﹤0.01%	3968
2022 Q3	$22K	Buy	12,154 +532	+5%	+$1.59K	﹤0.01%	3967
2022 Q2	$36K	Buy	+11,622	New	+$71K	﹤0.01%	4014

Other funds holding PRDS

FCMV

Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

Invesco's PRDS Position: Q2 2023 in Review

Invesco sold out of Pardes Biosciences, Inc. Common Stock (PRDS) in Q2 2023, closing a stake of 11,333 shares — an estimated $15K sold.

Invesco first reported a position in PRDS in Q2 2022 and held it in 4 quarters. The position peaked at $36K in Q2 2022. 59 funds tracked by Wall St. Rank hold PRDS as of Q2 2023.

Invesco reported no remaining Pardes Biosciences, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Invesco sold 11,333 Pardes Biosciences, Inc. Common Stock shares in Q2 2023, an estimated $15K.
Invesco first reported a position in Pardes Biosciences, Inc. Common Stock in Q2 2022 and held it in 4 quarters.
Invesco's Pardes Biosciences, Inc. Common Stock position peaked at $36K in Q2 2022.
59 funds tracked by Wall St. Rank held Pardes Biosciences, Inc. Common Stock as of Q2 2023.

Based on Invesco's 13F filing for Q2 2023, filed 11 Aug 2023.